Info

Nanodisc Inc. is a privately-held life science start-up created to commercialize its innovative nanoscale technology in the biopharmaceutical space. The primary focus of the Company is the development of Nanodiscs as a therapeutic and vaccine delivery platform. Corporate highlights include: Unique, proprietary Nanodisc platform for delivery, imaging and diagnostics, target discovery and validation, lead generation and optimization Pursuing multiple high-value drug and vaccine delivery applications characterized by substantial unmet need and market opportunity with clinical entry of first candidate anticipated in 2009 Continued alliance development with "best-in-class" partners to advance discovery assets Experienced management team supported by advisors and consultants with substantial domain expertise Exclusive license from the University of Illinois with allowance and issuance on generic composition of matter patents and further IP development underway Funding from IllinoisVENTURES and the Illinois Emerging Technology Fund Resources , Technology , Partnering , Media , Investors , Careers